Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 3;12:4670. doi: 10.1038/s41467-021-24836-9

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 7 — a TMB distributions of cases grouped by tumor type and then breed. Only groups with ≥10 tumors are shown, with n = 15, 28, 70, 14, 16, 11, 17, 44, 16, 21, 25, 21, 25 and 42 independent tumors from left to right. Two-sided Wilcoxon tests were conducted, with ** and * representing unadjusted p = 0.009 and 0.01, respectively, and fold-changes shown. b TMB distributions of tumors grouped by breed, tumor type, and finally TP53 (top) or PIK3CA (bottom) mutation status. Only groups with TP53 (or PIK3CA) wild-type and mutant-combined tumors of ≥10 are shown, with n = 15, 27, 1, 66, 4, 12, 2, 16, 10, 1, 17, 15, 1, 12, 13, 8, 13, 39, 5, 21, 14, 11, 14 and 28 (top) and n = 12, 3, 18, 10, 41, 29, 8, 6, 10, 6, 6, 5, 17, 16, 24, 1, 21, 44, 21, 25, 29 and 13 (bottom) independent tumors left to the right. Two-sided Wilcoxon tests were conducted, with *, **, and ** from left to right representing unadjusted p = 0.04, 0.003, and 0.008, respectively, and fold-changes shown. Source data are provided as a Source Data file.